Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Sale
Common Stock
2023-07-03$25.65/sh−1,004$25,749→ 105,839 total
Footnotes (1)
- [F1]Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.